Ophthalmic Imaging Equipment Market is Predicted to Reach US$ 3,538.7 Million by 2034, Expanding at a CAGR of 4.4% | Fact.MR

The global ophthalmic imaging equipment market is estimated to be valued at US$ 2,305.7 million in 2024. Demand for advanced imaging technologies is growing steadily, driven by ongoing innovations in modalities such as fundus photography and Optical Coherence Tomography (OCT).

Rising incidences of vision-related conditions-particularly diabetic retinopathy and age-related macular degeneration-are fueling the need for accurate and efficient diagnostic tools. In response, the market is expected to expand at a steady CAGR of 4.4% from 2024 to 2034, ultimately reaching a value of approximately US$ 3,538.7 million by the end of the forecast period.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9655

What Are the Prominent Factors Driving the Global Ophthalmic Imaging Equipment Market?

"Rising Diabetic Population and Increased Focus on Routine Eye Examinations Are Fueling Market Expansion"

A significant driver of the ophthalmic imaging equipment market is the increasing global prevalence of diabetes, which heightens the risk of diabetic retinopathy-a leading cause of vision loss. This trend has accelerated the demand for advanced diagnostic tools to detect and monitor eye complications early.

Additionally, growing awareness about preventive eye care and the importance of routine eye checkups is contributing to higher adoption rates of ophthalmic imaging technologies. The broader patient base, including those with age-related macular degeneration and other chronic eye conditions, is creating substantial growth opportunities for manufacturers focused on innovative and precise ophthalmic diagnostic solutions.

Country-wise Insights

In 2024, North America is projected to hold approximately 36.1% of the global ophthalmic imaging equipment market, with revenues reaching around US$ 833 million. The region's growth is being driven by the rising demand for compact and efficient retinal imaging systems, particularly in response to the increasing emphasis on point-of-care diagnostics within clinics and primary care environments.

According to Fact.MR, the adoption of ophthalmic imaging equipment across North America is expected to grow at a steady CAGR of 4.5% through 2034. This consistent growth trajectory is anticipated to boost the region's market value to approximately US$ 1,298 million by the end of the forecast period.

Category-wise Insights

Among the various ophthalmic imaging technologies available, general eye examination products are the most widely used by specialists for diagnostics, followed closely by retina and glaucoma examination devices. In 2024, general eye examination solutions are projected to account for 43.8% of the global market, while retina and glaucoma-related products are expected to contribute 43.1% of the overall revenue.

The preference for general eye examination equipment stems from their customizable features, which enhance diagnostic accuracy and streamline clinical workflows. This has driven their widespread adoption across diverse healthcare settings. Looking ahead, the retina and glaucoma examination segment is anticipated to grow at a faster pace, with a projected CAGR of 5.5% through 2034, compared to a 3.5% CAGR for general eye examination products.

Competitive Landscape

Leading companies in the ophthalmic imaging equipment market include Essilor Instruments, Haag-Streit AG, Carl Zeiss AG, Johnson & Johnson Vision Care, Alcon, Canon Inc., Quantel Medical Inc., Halma plc, Nidek Co., Ltd., and Topcon Corporation, among others.

These established players are strengthening their market position through strategic collaborations with healthcare institutions, enabling wider adoption of their diagnostic technologies. Their brand equity and technological expertise position them favorably in a competitive market landscape.

Emerging entrants with the capacity to invest in next-generation imaging technologies are also gaining traction. Their ability to deliver advanced, user-friendly solutions compatible with modern diagnostic workflows is attracting interest from healthcare providers looking to enhance clinical efficiency and patient outcomes.

Recent Industry Developments

July 2022: AbbVie Group entered a strategic partnership with iSTAR Medical SA to develop and commercialize MINIject, a minimally invasive glaucoma surgery (MIGS) device aimed at treating glaucoma patients more effectively.
May 2021: Lumenis Ltd. received De Novo approval from the USFDA for its intense pulsed light (IPL) device. This innovative technology is designed to treat meibomian gland dysfunction (MGD)-a leading cause of dry eye disease-demonstrating the growing role of light-based therapy in ophthalmology.

Browse Full Report:https://www.factmr.com/report/ophthalmic-imaging-equipment-market

Key Segments Covered by Ophthalmic Imaging Equipment Industry Survey Report

By Product Type:
Retina and Glaucoma Examination Products
Optical Coherence Tomography (OCT)
Ophthalmoscopes
Direct Ophthalmoscopes
Indirect Ophthalmoscopes
Perimeters
Fundus Cameras
General Eye Examination Products
Retinal Ultrasound Imaging Systems
A- Scan
A/B Scan
B- Scan
Auto Refractors & Keratometers
Slit Lamps
Hand Held
Table Mount
Tonometer's
Lensometers
Phoropters
Projectors
Acuity Systems
Cornea and Cataract Examination Products
Corneal Topography Systems
Optical Biometry Devices
Wavefront Aberrometers
Specular Microscopy
Ophthalmic Examination Chairs
Ophthalmic Examination Stands
By End User Verticals:
Hospitals
Ophthalmology Clinics
Optometry Clinics
Ambulatory Surgical Centers
Optical shop
Other End User Verticals
By Region:
North America Market
Europe Market
Latin America Market
East Asia Market
South Asia & Oceania Market
Middle East & Africa (MEA) Market

Check out More Related Studies Published by Fact.MR:

Fetal and Neonatal Heart Monitor Market
https://www.factmr.com/report/750/fetal-and-neonatal-heart-monitor-market
Microscopy Devices Market
https://www.factmr.com/report/4796/microscopy-devices-market
Peptide Based Infection Therapeutics Market
https://www.factmr.com/report/188/peptide-based-infection-therapeutics-market
Medical Imaging Phantoms Market
https://www.factmr.com/report/5119/medical-imaging-phantoms-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.